GREENLIGHT ADDSTAT
Report
- Report Number
- 2937094-2011-00577
- Event Type
- Malfunction
- Date Received
- April 6, 2011
- Date of Event
- October 2, 2010
- Report Date
- October 4, 2010
- Manufacturer
- AMERICAN MEDICAL SYSTEMS, INNOVATION CENTER - SILICON VALLEY
- Product Code
- GEX
- PMA / PMN Number
- K062719
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE EVENT DESCRIPTION THE CUSTOMER REPORTED TO AMS DID NOT INDICATE A POTENTIAL PT SAFETY ISSUE. THE DEVICE WAS SUBSEQUENTLY RETURNED TO AMS AND ANALYZED. THE INFO FROM THIS FAILURE ANALYSIS WAS REC'D ON (B)(4) 2011 AND THE RESULTS OF THE FAILURE ANALYSIS INDICATED THAT AN MDR WAS REQUIRED. THE FAILURE ANALYSIS DISCLOSED THAT THE FIBER CAP REGION BURNED AND/OR MELTED, THE CAP REMAINED INTACT AND ATTACHED. THE SHRINK TUBE AND/OR FIBER JACKET MELTED AND/OR BURNED. THE BEVELED SECTION MELTED AND EXHIBITED BURNT GLUE. THE FIBER CAP GENERALLY EXHIBITED SOME/ALL OF CHAR, DEVITRIFICATION, CRATER AND MELTED GLASS. THIS DEVICE FAILURE IS ASSOCIATED WITH A LACK OF COOLING. THE ROOT CAUSE OF THE DEVICE FAILURE WAS DETERMINED TO BE HEAT ACCUMULATION. THE PRODUCT LABELING (PRODUCT INSERT 0127-1410) WARNS THAT TISSUE CONTACT OR TISSUE PROBING MAY CAUSE FIBER DAMAGE OR BREAKAGE. THE PRODUCT LABELING ALSO WARNS OF POSSIBLE CAP DETACHMENT IN THE PT AND INSTRUCTIONS FOR RETRIEVING.
IT WAS REPORTED BY A CUSTOMER ON (B)(6) 2010, THERE WAS DIMINISHED VAPORIZATION; THERE WAS SIGNIFICANTLY DIMINISHED VAPORIZATION EFFICIENCY AT 13,145 JOULES. A FAILURE ANALYSIS, CONDUCTED BY AN AMERICAN MEDICAL SYSTEMS QUALITY ENGINEER, DISCLOSED THAT THE FIBER CAP REGION BURNED AND/OR MELTED, THE CAP REMAINED INTACT AND ATTACHED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GREENLIGHT ADDSTAT | SURGICAL FIBER | GEX | AMERICAN MEDICAL SYSTEMS, INNOVATION CENTER - SILICON VALLEY | NA | 023H |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |